Impact of fluoroquinolone cascade reporting of urine samples on antibiotic prescribing rates in a network of urgent care clinics

Brittani M Weichman; Amanda M Bushman; Kathie L Rogers; Rossana Rosa

doi:10.1017/ash.2022.227

Impact of fluoroquinolone cascade reporting of urine samples on antibiotic prescribing rates in a network of urgent care clinics

Antimicrob Steward Healthc Epidemiol. 2022 Jun 20;2(1):e97. doi: 10.1017/ash.2022.227. eCollection 2022.

Authors

Brittani M Weichman¹, Amanda M Bushman¹, Kathie L Rogers², Rossana Rosa^{3

4}

Affiliations

¹ Department of Pharmacy, UnityPoint Health, Des Moines, Iowa.
² Pathology Laboratory, Des Moines, Iowa.
³ Department of Medicine, University of Iowa-Des Moines, Des Moines, Iowa.
⁴ Infectious Diseases Service, UnityPoint Health, Des Moines, Iowa (Present affiliations: Microbiology Laboratory, Nebraska Medicine, Omaha, Nebraska [K.L.R.] and Department of Quality and Patient Safety, Jackson Health System, Miami, Florida [R.R.]).

Abstract

Cascade reporting is an antimicrobial stewardship strategy that has been successfully implemented in inpatient settings, but evidence of its impact on outpatient settings is scarce. We report on the impact on fluroquinolone prescribing at a network of urgent care clinics following the implementation of cascade reporting of Enterobacterales in urine cultures.